Company news
XBiotech Inc. news in 2020
XBiotech Inc.'s news releases, calls and decks from 2020, newest first.
XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail
November 18, 2020
XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections
September 20, 2020
XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
August 23, 2020
XBiotech Discovers COVID-19 Candidate Therapy
August 16, 2020
XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1⍺ Therapy
July 21, 2020
XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke
July 13, 2020
XBiotech Identifies “Super Bloods” for the Development of a True Human™ COVID-19 Therapy
April 30, 2020
XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1⍺)
April 13, 2020
XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients
April 2, 2020
XBiotech Announces Preliminary Results of Tender Offer
February 12, 2020
Corrected Press Release: XBiotech Announces Preliminary Results of Tender Offer
February 12, 2020
XBiotech Commences Tender Offer to Purchase up to $420,000,000 of its Shares
January 13, 2020